ReviewNeuro-oncology2013

IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma.

Chunzhi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.